Categories
Windlas Biotech Limited — Board Meeting, 21-05-2026: Outcome of Board Meeting
21-05-2026 · 05:05 pm
Windlas Biotech's Board approved Q4 & FY26 consolidated results: Revenue at Rs 904.09 Cr, Profit at Rs 66.46 Cr. The Board also proposed a dividend of Rs 6.30/share and completed a Rs 47 Cr share buyback.
No comments yet. Be the first to comment!